CLINICAL INFECTIOUS DISEASES, vol.61, no.3, pp.324-331, 2015 (SCI-Expanded)
Background. Anti-cancer treatment and the cancer population have evolved since the last European Organisation for Research and Treatment of Cancer (EORTC) fungemia survey, and there are few recent large epidemiological studies.